Showing results (1-10 of 400) with videos related to

Sort By:
Pageof 40
Cancer Immunology Research|September 5, 2014
NF-κB, an active player in human cancersYifeng Xia, Shen Shen, Inder M Verma
Cancer Cell|February 13, 2007
Inflammatory tales of liver cancerAlexander Hoffmann, Yifeng Xia, Inder M Verma
Immunological Reviews|March 23, 2012
IKK biologyFei Liu, Yifeng Xia, Aaron S Parker, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2015
Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinomaNarayana Yeddula, Yifeng Xia, Eugene Ke, et al.
Science Advances|January 30, 2016
Targeting NF-κB in glioblastoma: A therapeutic approachDinorah Friedmann-Morvinski, Rajesh Narasimamurthy, Yifeng Xia, et al.
Molecular Cancer Research : MCR|March 11, 2018
Targeting CREB Pathway Suppresses Small Cell Lung CancerYifeng Xia, Cheng Zhan, Mingxiang Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCPYifeng Xia, Roanna C Padre, Tatiana Hurtado De Mendoza, et al.
Science Translational Medicine|November 21, 2014
A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycinYifeng Xia, Yi-Liang Liu, Yonghua Xie, et al.
Nature Cell Biology|February 14, 2012
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer modelYifeng Xia, Narayana Yeddula, Mathias Leblanc, et al.
Plos One|October 4, 2011
Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activationKotaro Suzuki, Samantha H Murphy, Yifeng Xia, et al.
Pageof 40